Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) has issued an update.
Concord Healthcare Group Co., Ltd. held its 2026 extraordinary general meeting in Beijing, with shareholders representing about 27.03% of the company’s issued share capital in attendance and all directors and supervisors present. The meeting was conducted in compliance with PRC company law and the firm’s articles, and vote-taking was overseen by Computershare Hong Kong Investor Services Limited as scrutineer.
Shareholders approved a special resolution authorizing the company to apply to financial institutions for a comprehensive credit line and to provide related guarantees in 2026, with approximately 98.88% of votes cast in favor and 1.12% against. The strong backing for this financing framework enhances the company’s flexibility to secure credit facilities and support its operational and strategic funding needs in the coming year, signalling broad shareholder support for its financial plans.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$1.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a PRC-incorporated healthcare company listed in Hong Kong, with both H shares and domestic shares in issue. The group operates within China’s medical services and healthcare sector, serving patients and institutional clients while accessing onshore and offshore capital markets through its dual-share structure.
Average Trading Volume: 382,053
Technical Sentiment Signal: Sell
Current Market Cap: HK$979.6M
See more insights into 2453 stock on TipRanks’ Stock Analysis page.